Phenoxybenzamine

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

(±)--Benzyl-(2-chloroethyl)-(β-phenoxyisopropyl)-amine; CAS number: 59-96-1; Dibenzylin; (RS)-Benzyl-(2-chloroethyl)-(β-phenoxyisopropyl)-amine; (RS)-N-Benzyl-N-(2-chloroethyl)-1-(phenoxy)-2-aminopropane (IUPAC)

Classification
This section has been translated automatically.

Phenoxybenzamine is a drug with the molecular formula C18H22ClNO and a molar mass of 303.83 g-mol-1, which belongs to the group of alpha blockers (α sympatholytics; α receptor antagonists). Phenoxybenzamine has a peripheral vasodilating effect and is used as an antihypertensive agent in pheochromocytoma. Phenoxybenzamine is the only substance that inhibitsα1 andα2 receptors in therapeutic doses (Graefe et al. KH 2016).

Pharmacodynamics (Effect)
This section has been translated automatically.

Phenoxybenzamine exerts its effect in the arterial vessels by irreversible and non-selective blockade of α1-adrenoceptors. This causes the peripheral arterial vessels to dilate, vascular resistance decreases and afterload and blood pressure decrease. These effects are enhanced by a central attenuating effect due to a blockade of postsynaptic α1-adrenoceptors and presynapticα2-adrenoceptorsvia a reduction of sympathetic activity. The consequences include vasodilatation and increased gastrointestinal activity.

The positive effect on bladder voiding disorders as a result of an increased α-adrenergic tone of the sphincter also results from the alpha-receptor blockade. As a result, the outlet resistance of the bladder is reduced and urination is normalised.

Dosage and method of use
This section has been translated automatically.

Urinary bladder emptying disorders: In the case of neurogenic bladder emptying disorders, phenoxybenzamine is taken by adults for a short period of time at an initial dose of 10 mg/day. The dosage can be slowly increased by 10 mg every 4-7 days. The maximum daily dose is 60 mg daily, divided into two to three single doses.

Preoperative control of blood pressure in pheochromocytoma: Phenoxybenzamine therapy is started one to three weeks before the planned procedure with an initial dose of 10 mg/day. The daily dose can be increased up to 100 mg/day.

Undesirable effects
This section has been translated automatically.

Side effects can occur especially at the beginning of the treatment. The most serious side effect characteristic of alpha-receptor blockers is orthostatic hypotension. Side effects by frequency:

Very common:

  • dizziness, light-headedness
  • orthostatic hypotension
  • Miosis
  • Reflex Tachycardia
  • Swelling of the nasal mucosa.

Frequently:

  • pronounced hypotension.

Literature
This section has been translated automatically.

  1. Graefe KH et al. Autonomic Nervous System. In: Graefe KH et al. (Eds) Pharmacology and Toxicology. Georg Thieme Publisher Stuttgart S.97

Outgoing links (1)

Pheochromocytoma;

Authors

Last updated on: 29.10.2020